Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson showed strong growth, especially in pharmaceuticals, while its less-mature biotechnology cousins take a beating.

  • untitled
CNNMoney assistant managing editor Paul LaMonica highlights the latest news from Wall Street and what's moving the markets in his daily investing commentary.
@LaMonicaBuzz